We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Exxon Mobil, Thermo Fisher Scientific, Costco, Applied Materials and Automatic Data Processing
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 25, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Exxon Mobil Corporation (XOM - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) , Costco Wholesale Corporation (COST - Free Report) , Applied Materials, Inc. (AMAT - Free Report) and Automatic Data Processing, Inc. (ADP - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Exxon Mobil, Thermo Fisher and Costco
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil, Thermo Fisher Scientific and Costco. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Exxon Mobil shares have outperformed the Zacks Integrated International Oil industry over the past year (+52.7% vs. +27.1%). The Zacks analyst believes that major discoveries in the Stabroek Block have enhanced prospects for ExxonMobil's upstream businesses.
ExxonMobil’s bellwether status in the energy space, optimal integrated capital structure that has historically produced industry-leading returns and management’s track record of capex discipline across the commodity price cycle make it a relatively lower-risk energy sector play.
Also, the leading integrated energy company has significant lower debt exposure as compared to other integrated majors. Overall, ExxonMobil is not focusing aggressively on production in order to win back investors but instead is making every effort to preserve shareholder’s capital while lowering costs.
Thermo Fisher’s shares have gained +6.7% over the last six months against the Zacks Medical Instruments industry’s gain of +3.6%. The Zacks analyst believes that Thermo Fisher is expanding inorganic growth profile with several takeovers including the Advanced Bioprocessing buyout from BD and Patheon.
The company ended the fourth quarter as well as full-year 2020 with better-than-expected numbers. It delivered an outstanding quarterly performance with strong organic growth leveraging on capacity to extend support amid pandemic.
A strong capital structure looks also encouraging. However, the coronavirus outbreak has massively disrupted the global supply chain. Foreign currency fluctuations and competitive landscape are major downsides.
Shares of Costco have lost -6.8% in the past three months against the Zacks Discount Retail industry’s loss of -1.4%. The Zacks analyst believes that the company’s growth strategies, better price management, decent membership trend and increasing penetration of e-commerce business reinforce its position.
Costco put up a decent performance in second-quarter fiscal 2021, wherein both the top and the bottom lines grew year over year. While earnings missed the Zacks Consensus Estimate, revenues surpassed the same.
Also, Costco maintained a stellar comps run. However, weak margins remain a concern. Any deleverage in SG&A rate as well incremental wages and sanitation costs cannot be ignored.
Other noteworthy reports we are featuring today include Applied Materials and Automatic Data Processing.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Exxon Mobil, Thermo Fisher Scientific, Costco, Applied Materials and Automatic Data Processing
For Immediate Release
Chicago, IL – March 25, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Exxon Mobil Corporation (XOM - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) , Costco Wholesale Corporation (COST - Free Report) , Applied Materials, Inc. (AMAT - Free Report) and Automatic Data Processing, Inc. (ADP - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Exxon Mobil, Thermo Fisher and Costco
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil, Thermo Fisher Scientific and Costco. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Exxon Mobil shares have outperformed the Zacks Integrated International Oil industry over the past year (+52.7% vs. +27.1%). The Zacks analyst believes that major discoveries in the Stabroek Block have enhanced prospects for ExxonMobil's upstream businesses.
ExxonMobil’s bellwether status in the energy space, optimal integrated capital structure that has historically produced industry-leading returns and management’s track record of capex discipline across the commodity price cycle make it a relatively lower-risk energy sector play.
Also, the leading integrated energy company has significant lower debt exposure as compared to other integrated majors. Overall, ExxonMobil is not focusing aggressively on production in order to win back investors but instead is making every effort to preserve shareholder’s capital while lowering costs.
(You can read the full research report on Exxon Mobil here >>>)
Thermo Fisher’s shares have gained +6.7% over the last six months against the Zacks Medical Instruments industry’s gain of +3.6%. The Zacks analyst believes that Thermo Fisher is expanding inorganic growth profile with several takeovers including the Advanced Bioprocessing buyout from BD and Patheon.
The company ended the fourth quarter as well as full-year 2020 with better-than-expected numbers. It delivered an outstanding quarterly performance with strong organic growth leveraging on capacity to extend support amid pandemic.
A strong capital structure looks also encouraging. However, the coronavirus outbreak has massively disrupted the global supply chain. Foreign currency fluctuations and competitive landscape are major downsides.
(You can read the full research report on Thermo Fisher here >>>)
Shares of Costco have lost -6.8% in the past three months against the Zacks Discount Retail industry’s loss of -1.4%. The Zacks analyst believes that the company’s growth strategies, better price management, decent membership trend and increasing penetration of e-commerce business reinforce its position.
Costco put up a decent performance in second-quarter fiscal 2021, wherein both the top and the bottom lines grew year over year. While earnings missed the Zacks Consensus Estimate, revenues surpassed the same.
Also, Costco maintained a stellar comps run. However, weak margins remain a concern. Any deleverage in SG&A rate as well incremental wages and sanitation costs cannot be ignored.
(You can read the full research report on Costco here >>>)
Other noteworthy reports we are featuring today include Applied Materials and Automatic Data Processing.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.